Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Participants”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05858788
What this trial is testing

A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.

Who this might be right for
Rheumatoid Arthritis
Sanofi 10
Early research (Phase 1)Looking for participantsNCT06576271
What this trial is testing

GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 142
Early research (Phase 1)Study completedNCT06869018
What this trial is testing

LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants

Who this might be right for
HealthyType 2 Diabetes Mellitus (T2D)
Eli Lilly and Company 92
Early research (Phase 1)Study completedNCT01223339
What this trial is testing

Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Study completedNCT03689153
What this trial is testing

JNJ-63733657 in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT03188783
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 32
Early research (Phase 1)Study completedNCT04044053
What this trial is testing

Relative Bioavailability Study of a Modified-Release Formulation of PF-06865571 in Healthy Adult Participants

Who this might be right for
Healthy Participants
Pfizer 12
Early research (Phase 1)Study completedNCT03801967
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose Administration

Who this might be right for
Heart Failure
AstraZeneca 28
Early research (Phase 1)Study completedNCT01799603
What this trial is testing

A Pharmacokinetic Study to Assess the Effect of Food in Healthy Male Participants Receiving TMC435

Who this might be right for
Healthy
Janssen Research & Development, LLC 24
Early research (Phase 1)Study completedNCT03916250
What this trial is testing

Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants

Who this might be right for
Healthy
Pfizer 20
Early research (Phase 1)Study completedNCT03002025
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 48
Early research (Phase 1)Study completedNCT02478333
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT04544826
What this trial is testing

JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous Doses

Who this might be right for
Healthy
Janssen Research & Development, LLC 24
Early research (Phase 1)Study completedNCT01958489
What this trial is testing

Evacetrapib in Japanese and Non-Japanese Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT02555124
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT05885451
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants

Who this might be right for
Chronic Graft-versus-Host Disease (cGVHD)
Amgen 18
Early research (Phase 1)Study completedNCT03055962
What this trial is testing

Study to Evaluate the Safety and Tolerability of a Once Daily Dose of 50 mg E2609 in Healthy Japanese Subjects

Who this might be right for
Healthy Participants
Eisai Co., Ltd. 16
Early research (Phase 1)Study completedNCT04223960
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants

Who this might be right for
Healthy Volunteers
EA Pharma Co., Ltd. 184
Early research (Phase 1)Study completedNCT04459767
What this trial is testing

Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated Triglycerides

Who this might be right for
Healthy
Pfizer 12
Early research (Phase 1)Study completedNCT02104765
What this trial is testing

LY2951742 in Healthy Japanese and Caucasian Participants

Who this might be right for
Migraine Disorders
Eli Lilly and Company 45
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation